Live from the NIH registry
Studies recruiting near Pensacola right now
Top 25 of 137 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Ascension Sacred Heart — Pensacola, Florida (2.1 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Sacred Heart Hospital — Pensacola, Florida (2.1 mi)
· Sponsor: NRG Oncology
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Sacred Heart Medical Oncology Group — Pensacola, Florida (2.1 mi)
· Sponsor: Gilead Sciences
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Baptist Hospital Cardiology — Pensacola, Florida (2.1 mi)
· Sponsor: Novo Nordisk A/S
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
Phase 2
Interventional 324 participants sought
Retina Specialty Institute — Pensacola, Florida (2.1 mi)
· Sponsor: ONL Therapeutics
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Orthomicrospine — Pensacola, Florida (2.1 mi)
· Sponsor: Boston Scientific Corporation
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
SEC Clinical Research — Pensacola, Florida (2.1 mi)
· Sponsor: Novo Nordisk A/S
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Sacred Heart Hospital — Pensacola, Florida (2.1 mi)
· Sponsor: SWOG Cancer Research Network
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Chronic Myelogenous Leukemia - Chronic Phase
N/A
Observational 1,000 participants sought
Sacred Heart Medical Oncology — Pensacola, Florida (2.1 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Southern Cancer Center, PC — Foley, Alabama (29.4 mi)
· Sponsor: Pfizer
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Pensacola, Florida (2.1 mi)
· Sponsor: TG Therapeutics, Inc.
The ArtixASCEND Study
Acute Lower Limb Arterial Occlusion
N/A
Interventional 250 participants sought
Ascension Sacred Heart Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Inari Medical
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Age-Related Macular Degeneration
Phase 1
Interventional 42 participants sought
Retina Specialty Institute — Pensacola, Florida (2.1 mi)
· Sponsor: Astellas Institute for Regenerative Medicine
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Children's Oncology Group
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration, nAMD
Phase 3
Interventional 304 participants sought
Advanced Research, LLC — Pensacola, Florida (2.1 mi)
· Sponsor: Amgen
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Children's Oncology Group
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
USOR - Woodlands Medical Specialists — Pensacola, Florida (2.1 mi)
· Sponsor: Mirati Therapeutics Inc.
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 190 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Children's Oncology Group
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Metastatic Urothelial Cancer
Phase 2
Interventional 827 participants sought
Woodlands Medical Specialists, PA — Pensacola, Florida (2.1 mi)
· Sponsor: Gilead Sciences
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Children's Oncology Group
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Ascension Sacred Heart — Pensacola, Florida (2.1 mi)
· Sponsor: Alleviant Medical, Inc.